2016

 

  1. Tomic K, Westerberg M, Robinson D, Garmo H, Stattin P. Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden, Acta Oncol. 2016 Dec;55(12):1461-1466. Sammanfattning
  2. Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, Adami HO, Stattin P, Nyrén O, Mucci LA. Snus use, smoking and survival among prostate cancer patients, Int J Cancer. 2016 Dec 15;139(12):2753-2759. Sammanfattning
  3. Crawley D, Garmo H, Rudman S, Stattin P, Häggström C, Zethelius B, Holmberg L, Adolfsson J, Van Hemelrijck M. Association between duration and type of Androgen Deprivation Therapy and risk of diabetes in men with prostate cancer, Int J Cancer. 2016 Dec 15;139(12):2698-2704. Sammanfattning
  4. Thomsen FB, Folkvaljon Y, Brasso K, Loeb S, Robinson D, Egevad L, Stattin P. Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy, J Surg Oncol. 2016 Nov;114(6):664-670. Sammanfattning
  5. Loeb S, Stattin P. Further Evidence against a Causal Association between Erectile Dysfunction Drugs and Melanoma, Eur Urol. 2016 Nov;70(5):816-817. Sammanfattning
  6. Loeb S, Folkvaljon Y, Robinson D, Schlomm T, Garmo H, Stattin P. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment, Eur Urol. 2016 Nov;70(5):824-828. Sammanfattning
  7. Fridriksson JÖ, Folkvaljon Y, Nilsson P, Robinson D, Franck-Lissbrant I, Ehdaie B, Eastham JA, Widmark A, Karlsson CT, Stattin P. Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study, Scand J Urol. 2016 Oct;50(5):338-45. Sammanfattning
  8. O’Farrell S, Sandström K, Garmo H, Stattin P, Holmberg L, Adolfsson J, Van Hemelrijck M. Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation, BJU Int. 2016 Sep;118(3):391-8. Sammanfattning
  9. Bjartell A, Bottai M, Persson J, Bratt O, Damber JE, Stattin P, Akre O. Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort, Scand J Urol. 2016 Aug;50(4):255-9. Sammanfattning
  10. Loeb S, Folkvaljon Y, Robinson D, Makarov DV, Bratt O, Garmo H, Stattin P. Immediate versus delayed prostatectomy: Nationwide population-based study, Scand J Urol. 2016 Aug;50(4):246-54. Sammanfattning
  11. Björklund J, Folkvaljon Y, Cole A, Carlsson S, Robinson D, Loeb S, Stattin P, Akre O. Ninety-Day Postoperative Mortality after Robot-assisted Laparoscopic Prostatectomy and Retropubic Radical Prostatectomy. Nation-wide population-based study, BJU Int. 2016 Aug;118(2):302-6. Sammanfattning
  12. Bratt O, Drevin L, Akre O, Garmo H, Stattin P. Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study, J Natl Cancer Inst. 2016 Jul 10;108(10). Sammanfattning, Fulltext
  13. Plym A, Voss M, Stattin P, Lambe M. Assessing Work Disability After Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.01.005: The Challenge of Assessing Work Disability, 2016 Jul;70(1):73-74. Sammanfattning, Fulltext
  14. Plym A, Chiesa F, Voss M, Holmberg L, Johansson E, Stattin P, Lambe M. Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study, Eur Urol. 2016 Jul;70(1):64-71. Sammanfattning, Fulltext
  15. Lundström KJ, Folkvaljon Y, Loeb S, Axelson AB, Stattin P, Nordin P. Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy, Scand J Urol. 2016 Jun;50(3):155-9. Sammanfattning
  16. Arthur R, Møller H, Garmo H, Holmberg L, Stattin P, Malmstrom H, Lambe M, Hammar N, Walldius G, Robinson D, Jungner I, Hemelrijck MV. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories, Cancer Med. 2016 Jun;5(6):1307-18. Sammanfattning
  17. Carlsson S, Drevin L, Loeb S, Widmark A, Franck Lissbrant I, Robinson D, Johansson E, Stattin P, Fransson P, Population-based study of long-term functional outcomes after prostate cancer treatmentm, BJU Int. 2016 Jun;117(6B):E36-45.  Sammanfattning
  18. Loeb S, Folkvaljon Y, Robinson D, Lissbrant IF, Egevad L, Stattin P. Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort, Eur Urol. 2016 Jun;69(6):1135-41. Sammanfattning, Fulltext
  19. Thomsen FB, Folkvaljon Y, Garmo H, Robinson D, Loeb S, Ingvar C, Lambe M, Stattin P. Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study, Int J Cancer. 2016 May 1;138(9):2154-60. Sammanfattning, Fulltext
  20. Loeb S, Lambe M, Stattin P. Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711, J Urol. 2016 Apr;195(4 Pt 1):1172-3. Sammanfattning
  21. Stattin P. Svenska kvalitetsregister slår hål på larmrapporter – Register med stora studiepopulationer ger liten risk för fynd baserade på slump eller förväxling, Läkartidningen 2016 Apr 20;113. Sammanfattning, Artikel
  22. Van Hemelrijck M, Folvaljon Y, Adolfsson J, Akre O, Holmberg L, Garmo H, Stattin P, Causes of death in men with localised prostate cancer: a nationwide, population-based study, BJU Int, 2016 Mar;117(3):507-14. Sammanfattning
  23. Van Hemelrijck M, Garmo H, Wigertz A, Nilsson P, Stattin P. Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base-a refined prostate cancer trajectory, Int J Epidemiol, 2016 Feb;45(1):73-82. Sammanfattning, Fulltext
  24. Thorstenson A, Garmo H, Adolfsson J, Bratt O. Cancer-specific mortality in men diagnosed with prostate cancer before age 50 years, a nationwide population-based study, J Urol. 2017 Jan;197(1):61-66. Sammanfattning
  25. Jan M, Bonn SE, Sjölander A, Wiklund F, Stattin P, Holmberg E, Grönberg H, Bälter K. The roles of stress and social support in prostate cancer mortality. Scand J Urol, 2016;50(1):47-55. Sammanfattning
  26. Stattin P, Sandin F, Sandbäck T, Damber JE, Franck Lissbrant I, Robinson D, Bratt O, Lambe M, Dashboard report on performance on select quality indicators to cancer care providers, Scand J Urol, 2016;50(1):21-8. Sammanfattning